Exercise Tolerance

"Exercise Tolerance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST.

Descriptor ID	D017079
MeSH Number(s)	G11.427.680.270
Concept/Terms	Exercise Tolerance Exercise Tolerance Tolerance, Exercise

Below are MeSH descriptors whose meaning is more general than "Exercise Tolerance".

Biological Sciences [G]
Musculoskeletal and Neural Physiological Phenomena [G11]
Musculoskeletal Physiological Phenomena [G11.427]
Physical Endurance [G11.427.680]
Exercise Tolerance [G11.427.680.270]

Below are MeSH descriptors whose meaning is related to "Exercise Tolerance".

Below are MeSH descriptors whose meaning is more specific than "Exercise Tolerance".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Exercise Tolerance" by people in this website by year, and whether "Exercise Tolerance" was a major or minor topic of these publications.

Bar chart showing 77 publications over 30 distinct years, with a maximum of 7 publications in 2025

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	1	2
1999	0	2	2
2000	0	1	1
2001	1	0	1
2002	0	1	1
2003	0	2	2
2004	0	1	1
2005	2	1	3
2006	2	1	3
2007	2	2	4
2008	1	3	4
2009	0	2	2
2010	2	2	4
2011	1	1	2
2012	1	5	6
2013	0	2	2
2014	1	1	2
2015	1	0	1
2016	1	2	3
2017	3	0	3
2018	3	0	3
2019	1	2	3
2020	0	2	2
2021	1	1	2
2022	1	0	1
2023	0	1	1
2024	2	4	6
2025	2	5	7
2026	0	2	2

Below are the most recent publications written about "Exercise Tolerance" by people in Profiles.

Veselka J, Gimeno R, Abraham TP, Barriales-Villa R, Claggett BL, Coats CJ, Hegde SM, Januzzi JL, Masri A, Miao ZM, Nassif ME, Olivotto I, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Wohltman A, Maron MS. Efficacy of Aficamten in Hypertrophic Cardiomyopathy Patients With Very-High Left Ventricular Outflow Tract Gradients. Am J Cardiol. 2026 Jul 01; 270:133-141.

View in: PubMed
Asghar A, Fonseca-Paricio M, Ravikumar N, Hammer MM, Forth V, Wagh A, Hogarth DK, Shafiq M. Sequential Bilateral Bronchoscopic Lung Volume Reduction for Residual Hyperinflation Following Successful Index Procedure in Pulmonary Emphysema: A Multicenter Study. J Bronchology Interv Pulmonol. 2026 Apr 01; 33(2).

View in: PubMed
Nassif ME, Garcia-Pavia P, Masri A, Merkely B, Pe?a-Pe?a ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett BL, Costabel JP, de Barros Correia E, Dybro AM, Elliott P, Lakdawala NK, Lewis GD, Mann A, Maron MS, Miao ZM, Nair A, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA, Spertus JA. Effect of Aficamten vs Metoprolol on Patient-Reported Health Status in Obstructive Hypertrophic Cardiomyopathy. J Am Coll Cardiol. 2026 Mar 03; 87(8):1046-1058.

View in: PubMed
Schulz A, Wallace TE, Chow K, Bi X, Amyar A, Rodriguez J, Ghanbari F, Maron MS, Rowin EJ, Kellmann P, Manning WJ, Nezafat R. Quantitative myocardial blood flow and perfusion reserve with exercise cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2025 Winter; 27(2):101988.

View in: PubMed
Campain J, Griskowitz C, Newlands C, Claggett BL, Kulac IJ, McGinnis S, Giverts I, Moreno F, Minasian A, Prasad C, Rupert L, Landsteiner I, Iskenderian N, Coats CJ, Lee MMY, Maron MS, Owens AT, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Wohltman A, Malhotra R, Lewis GD. Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial. Circulation. 2025 Oct 07; 152(14):990-1002.

View in: PubMed
Garcia-Pavia P, Maron MS, Masri A, Merkely B, Nassif ME, Pe?a-Pe?a ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, Correia EB, Dybro AM, Elliott P, Hegde SM, Lakdawala NK, Lewis GD, Mann A, Miao ZM, Nair A, Poulsen SH, Reant P, Schulze PC, Solomon SD, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA. Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2025 Sep 11; 393(10):949-960.

View in: PubMed
Landsteiner I, Masri A, Saberi S, Maron MS, McGinnis SL, Griskowitz C, Newlands CE, Barriales-Villa R, Owens AT, Lewis GD. Cardiopulmonary Exercise Testing for Characterization of Hypertrophic Cardiomyopathy: A Meta-Analysis. J Am Heart Assoc. 2025 Sep 02; 14(17):e039551.

View in: PubMed
Damluji AA, Tomczak CR, Hiser S, O'Neill DE, Goyal P, Pack QR, Foulkes SJ, Brown TM, Haykowsky MJ, Needham DM, Forman DE. Benefits of Cardiac Rehabilitation: Mechanisms to Restore Function and Clinical Impact. Circ Res. 2025 Jul 07; 137(2):255-272.

View in: PubMed
Norweg A, Oh C, DiMango A, Hofferber B, Spinner M, Stavrolakes K, Pavol M, Lindenauer P, Murphy CG, Simon NM. Mind the Breath: Feasibility of Capnography-Assisted Learned Monitored (CALM) Breathing for Dyspnea Treatment. J Cardiopulm Rehabil Prev. 2025 03 01; 45(2):118-131.

View in: PubMed
Suri R, Markovic D, Woo H, Arjomandi M, Barr RG, Bowler RP, Criner G, Curtis JL, Dransfield MT, Drummond MB, Fortis S, Han MK, Hoffman EA, Kaner RJ, Kaufman JD, Krishnan JA, Martinez FJ, Ohar J, Ortega VE, Paine R, Soler X, Woodruff PG, Hansel NN, Cooper CB, Tashkin DP, Buhr RG, Barjaktarevic IZ. The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2024 11 15; 210(10):1210-1218.

View in: PubMed

People

Explore

Similar Concepts

Top Journals